PERSONAL INFORMATION

                 ORCID ID: https://orcid.org/0000-0002-3684-9271

Scopus Author ID:  Scopus Author ID: 57188718151

Sex female | Date of birth 16/08/1980 | Nationality Egyptian

Languages:

Arabic (Mother tongue), English (Fluent written and spoken).

PROFESSIONAL EXPERIENCE:

Current position:

• Lecturer of medical oncology, Faculty of medicine, Suez University (started June 2021).
• Lecturer of medical oncology, medical oncology department, Armed Forces College of medicine (AFCM), started January 2021.
• Consultant of medical oncology, medical oncology department, Maadi Armed Forces medical compound (July 2018-till now).
• Consultant of medical oncology, Shefa Al-orman Hospital, Luxor (Started January 2019).

Work experience

• Lecturer of clinical research, biomedical research department, Armed Forces College of medicine (AFCM), starting July 2019 till June 2021.
• Lieutenant colonel Doctor, Egyptian armed forces medical corps (July 2016-December 2018).
• Major Doctor, Egyptian armed forces medical corps (January 2014-June 2016).
• Head of clinical research support team, Maadi armed forces medical compound (January 2016-December 2018).

• Specialist of medical oncology at Maadi armed forces medical compound, medical oncology department (January 2011-June 2018).
• Specialist of medical oncology at Wadi EL Nile hospital (January2013-January 2014).
• Specialist of medical oncology at the International Medical Center (October 2011- December 2012).
• Medical oncology consultant assistant (Prof. Hussein Khaled oncology clinic, 2010-2017)
• Resident in medical oncology department, Maadi armed forces medical compound (May 2005-December 2010).
• Visitor resident in medical oncology department at NCI, Cairo (January 2008-June 2009).

EDUCATION AND TRAINING

Educational background:

• MD of medical oncology, NCI, Cairo University, 2018.
• M.Sc. of medical oncology, NCI, Cairo University, 2010.
• M.B.B.CH of medicine and general surgery, Tanta University School of medicine, Tanta University, November 2003 (Very good with honors).
• ESMO certification exam (European society of medical oncology), September 2011.

Courses &training:

• Basics of pharmaco-economics (International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Egypt chapter), July 2016.

• ICH/GCP training workshop for investigators Maadi military Hospital September, 2016.

• 5th ESO Arab Countries Master-class in Clinical Oncology. 28-30 October 2016, Cairo, Egypt.

• NET-Novartis preceptorship, Guy’s and St Thomas’ (NHS foundation trust). 9-10 December, London,UK.

Publications:

• Patterns of care for colorectal cancer patients in a developing country: a multicenter study from Egypt. (First author), published in abstract form (ASUCOC 2014).

• Comparative Observational Study of Two Ethnic Population Groups of Patients with Hepatocellular Carcinoma. (Co-author)-Published:2014-citation: Fotopoulos G, Rashad N, Pentheroudakis G, Aboulkassem F, Khaled H, et al. (2014) Comparative Observational Study of Two Ethnic Population Groups of Patients with Hepatocellular Carcinoma. J Clin Exp Oncol 3:3. doi:10.4172/2324-9110.1000129

• Review on renal cell carcinoma and pregnancy: A challenging situation.

Khaled H, Al Lahloubi N, Rashad N. Review on renal cell carcinoma and pregnancy: A challenging situation. Journal of Advanced Research. 2016 Mar 31.

• A review on thyroid cancer during pregnancy: Multitasking is required.

Khaled H, Al Lahloubi N, Rashad N. A review on thyroid cancer during pregnancy: Multitasking is required. Journal of Advanced Research. 2016 Mar 2.

• Intraperitoneal chemotherapy and cytoreductive surgery for peritoneal metastases coupled with curative treatment of colorectal liver metastases: an updated systematic review.

Sarah El-Nakeep, Noha Rashad, Hani Oweira, Jan Schmidt, Daniel   Helbling, Anwar Giryes, Ulf Petrausch, Arianeb Mehrabi, Michael Decker, and Omar Abdel-Rahman.Expert Review of Gastroenterology & Hepatology Vol. 11 , Iss. 3,2017.

• Differential clinical pharmacology of rolapitant in delayed chemotherapy-induced nausea and vomiting (CiNv).  

Rashad N, Abdel-Rahman O. Differential clinical pharmacology of rolapitant in delayed chemotherapy-induced nausea and vomiting (CINV). Drug Des. Devel. Ther. 2017;11.

• Variations in clinicopathological features, treatment patterns, and outcomes of young adults with colorectal cancer in the United States and Egypt | OncologyPRO n.d. https://oncologypro.esmo.org/meeting-resources/esmo-2017-congress/Variations-in-clinicopathological-features-treatment-patterns-and-outcomes-of-young-adults-with-colorectal-cancer-in-the-United-States-and-Egypt (accessed March 13, 2020).

• Impact of age on clinical and pathological features as well as outcome in Egyptian patients with colorectal cancer (CRC).

Rashad N, Heeke AL, Khaled HM, Ali El din N, Abd El Motaal G, Wang H, et al. Impact of age on clinical and pathological features as well as outcome in Egyptian patients with colorectal cancer (CRC). J Clin Oncol 2018;36:600–600. doi:10.1200/jco.2018.36.4_suppl.600.

• Outcomes of treatment with sorafenib in Egyptian patients with hepatocellular carcinoma: a retrospective cohort study.

 Nada Y, Rashad N, Eissa M, Ghonaim A, Farag K, Saadawi I, et al. Outcomes of treatment with sorafenib in Egyptian patients with hepatocellular carcinoma: a retrospective cohort study. Expert Rev Gastroenterol Hepatol 2018;12:99–107. doi:10.1080/17474124.2018.1403898.

• Cost-effectiveness of Sorafenib versus Best Supportive Care in Advanced Hepatocellular Carcinoma in Egypt.

Hamdy Elsisi G, Nada Y, Rashad N, Carapinha J. Cost-effectiveness of sorafenib versus best supportive care in advanced hepatocellular carcinoma in Egypt. J Med Econ 2019;22:163–8. doi:10.1080/13696998.2018.1552432.

• Capecitabine based chemo-endocrine combination as first line treatment for metastatic Hormonal positive metastatic breast cancer: a phase II study.

      Rashad N, Abdelhamid T, Shouman SA, Nassar H, Omran MA, El Desouky ED, et al. Capecitabine-Based Chemoendocrine Combination as First-Line Treatment for Metastatic Hormone-Positive Metastatic Breast Cancer: Phase 2 Study. Clin Breast Cancer 2020;0. doi:10.1016/j.clbc.2019.12.012.

• Cost-effectiveness of six months versus 1-year adjuvant trastuzumab in HER2 positive early breast cancer in Egypt.

           Elsisi GH, Nada Y, Rashad N, Carapinha J, Noor AO, Almasri DM, et al. Cost-effectiveness of six months versus 1-year adjuvant trastuzumab in HER2 positive early breast cancer in Egypt. J Med Econ 2020:1–1. doi:10.1080/13696998.2020.1724682.

• Primary Osteosarcoma of the Urinary Bladder Metastatic to Lung.

Amira Elwy, Amr Soliman, Mohamed Maher, Yasmin Abdelhakam, Ali Saad, Mohamed Ahmed Abdul Latif Elsayed, Mohamed El-Kaffas, Noha Rashad, Nesreen Magdy.

J Med Cases. 2021;12(7):280-283
doi: https://doi.org/10.14740/jmc3613

• Resource Oriented Decision Making for Treatment of Metastatic Colorectal Cancer (mCRC) in a Lower-Middle Income Country: Egyptian Foundation of Medical Sciences (EFMS) Consensus Recommendations 2020.

Noha Rashad  1 , Mohamed Abdulla  2 , Mohamed Farouk  3 , Yasser Elkerm  4 , Salem Eid Salem  5 , Maha Yahia  5 , Amr S Saad  6 , Ahmed Hassan Abdel Aziz  6 , Ghada Refaat  6 , Ibrahim Awad  7 , Maha ElNaggar  8 , Khaled Kamal  6 , Basel Refky  9 , Mohamed Abdelkhalek  9 , Ahmed Touny  10 , Loay Kassem  2 , Emad Shash  5 , Abdelhay A Abdelhay  11 , Bahaa Eldin Mahmoud  11 , Karima Oualla  12 , Nesrine Chraiet  13 , Hussein AwadElkarim H Maki  14 , Yasser Abdel Kader 

      Cancer Manag Res. Feb 28;14:821-84  

      doi: 10.2147/CMAR.S340030. eCollection 2022.

Other activities:

• Managing editor of (Military medical Journal (MMJ), under publication and processing.

https://mmj.journals.ekb.eg/

• C.A.I.R.O. Journal club moderator (Critical appraisal initiative for research in oncology) from March 2014 and till now.

https://www.cairojournalclub.com/

• Secretary General & co-founder of EFMS (Egyptian foundation of medical sciences).

• Participated to the organization of the 1^st and 2^nd Immigrant Egyptian oncologists forum & Summit (IEOS 2016 &IEOF 2017).

• Participated to the organization of the 1^st, 2^nd and 3^rd conferences of Medical oncology department, Maadi armed Forces medical compound.

Areas of interest.

• Gastrointestinal malignancies.
• Breast cancer.
• Ovarian cancer.
• Real world data.
• Systematic reviews and meta-analysis.

Communication skills

Good communication skills gained through participation in the multidisciplinary teams as regard team work, proper knowledge exchange and how to explain my point of view in a clear way.

Organizational

 / managerial skills

• I have good experience with work with social activities as I am a secretary of non-profit organization that provide continuous medical education and research/critical appraisal skills to young oncologists.

Job-related skills

• I have good experience with medical research activities as regard conducting clinical trials, collection of data, statistical analysis and writing medical research paper.
• Also, I have good command of using the online medical resources and making systematic reviews according to the literature.

Computer skills

 l have good command of computer software especially office programs        like PowerPoint , word and excel .

Memberships

European Society Of Medical Oncology " ESMO" .

American Society Of Clinical Oncology "ASCO".

Other interests:

• Philosophy (planning to earn an academic degree).
• History (mainly Egyptology).
• Painting (shared in some exhibitions)

Referees:

Prof. Hussein Khaled.

Prof. Emeritus of Medical Oncology 

National Cancer Institute, Cairo University,

Member of UICC Board of Directors, 

Former Minister of Higher Education. 

Former Dean of National Cancer Insitute.

Email; khussein528@gmail.com

Phone no. +02 01222151040

Major Genreal Dr. Magdy Amin Aly.

Commander in chief, armed forces medical services.

Email: drmagdyamin@gmail.com

Phone no. +02 01001099151

Emad Shash, MBBCh, MSc, MD

General Manager.

Breast Cancer Comprehensive Center.

National Cancer Institute, Cairo University.

Head of Medical Oncology Department.

Sheffa Al Orman Comprehensive Cancer Center.